Document is current
Any future updates will be listed below
-
Authors
Luterbach, Courtney L.
Pasquale, Dana K.
Henderson, Heather I.
Cober, Eric
Richter, Sandra S.
Salata, Robert A.
Kalayjian, Robert C.
Watkins, Richard R.
Hujer, Andrea M.
Hujer, Kristine M.
Domitrovic, T. Nicholas
Doi, Yohei
Kaye, Keith S.
Evans, Scott
Fowler, Vance G. Jr.
Bonomo, Robert A.
Kreiswirth, Barry
Chen, Liang
Arias, Cesar A.
Moody, James
van Duin, David
,
Chambers, Chip
Hamasaki, Toshi
Patel, Robin
Cross, Heather
Harris, Anthony
Pettigrew, Melinda
van Duin, David
Boucher, Helen
Huntley, Clayton
Zou, Lanling
Raterman, Erica
Samuel, Tamika
Moon, Kyung
Hanson, Kim
Doi, Yohei
Holland, Thomas
Lodise, Tom
Shelburne, Sam
Banerjee, Ritu
Cosgrove, Sara
Paterson, David
Lautenbach, Ebbing
Mehigan, Maureen
Doernberg, Sarah
Perdue, Sam
Beigel, John
Roach, David
-
Funding
Funding for this research was provided by:
National Institute of Child Health and Human Development (R25HD079352)
National Institute of Allergy and Infectious Diseases (R01AI143910)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 29 May 2025
First Online: 29 July 2025
Declarations
:
: DvD reports grants and contracts from the NIH, Merck, and Shinogi, paid to his institution, outside of the published work; consultancy for Actavis, Tetraphase. Sanofi-Pasteur. MedImmune, Astellas, Merck, Allergan, T2Biosystems, Roche, Achaogen, Neumedicine, Shionogi, Pfizer, Entasis, Qpex, Wellspring, Karius, and Utility paid directly to him; honoraria from Pfizer; and an editor’s stipend from the British Society for Antimicrobial Chemotherapy (BSAC). RRW is a stockholder and employee of CVS Health; has received a grant from Allergan; and has been a paid consultant for bioMerieux outside of the published work. YD reports grants from the NIH, AMED, Shionogi and Entasis, paid to his institution, outside of the published work; consultancy for Gilead, Shionogi, GSK, Moderna, Pfizer, AbbVie, paid directly to him; and honoraria from Shionogi. KSK reports consultancy for Merck, Abbvie, Shiognogi, Carb-X, GSK, Xellia. RAB reports grants from Merck, Entasis, and Shionogi outside of the published work. The remaining authors declare no conflicts of interest.
